Stability indicating RP‐HPLC method development and validation for quantification of impurities in gonadotropin‐releasing hormone (Elagolix): Robustness study by quality by design
Biomedical Chromatography · 2024
DOI: 10.1002/bmc.6036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Lova Gani Raju Bandaru und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, GITAM School of Science, GITAM Deemed to be University, Hyderabad, Telanga, India. Hauptthemen laut MEDLINE: Chromatography, Reverse-Phase, Drug Contamination, Drug Stability, Limit of Detection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The purpose of this research was to establish and validate a reverse phase HPLC method for the determination of Elagolix impurities in pharmaceutical dosage form. Mobile phase A, consisting of 10 mM sodium dihydrogen phosphate (pH 6.0) and acetonitrile in a 95:5 v/v ratio, and mobile phase B, containing 85:10:5 v/v/v of acetonitrile, Milli‐Q water, and methanol, were used to achieve the method's specificity in the analytical column Kromasil 100‐C18 (250 mm × 4.6 mm, 5 μm). The gradient program includes (%B/Time [min]: 36/0, 36/10, 38/15, 85/55, 85/65, 36/67, and 36/75). The flow rate is 0.8 mL/min. The overall run duration is 75.0 min, the injection volume is 10.0 μL, and the detection is at 210 nm in UV. The samples were subjected to hydrolysis, oxidation, and heat conditions in order to facilitate their forced degradation. The procedure was validated and determined with the standards of ICH guidelines. From the LOQ to a concentration level of 200%, the linearity of the technique was ascertained. An accuracy range of LOQ to 150% was established for the method, and the average recovery was acceptable. Design of experiments, part of the quality by design idea, was used to prove the method's reliability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, GITAM School of Science, GITAM Deemed to be University, Hyderabad, Telanga, India.
- Laurus Generics, Inc., Berkeley, New Jersey, USA.
- Department of Pharmaceutical Analysis, GITAM School of Pharmacy, GITAM Deemed to be University, Hyderabad, Telangana, India.
- Department of Food Science, Purdue University, West Lafayette, Indiana, USA.
- School of Chemistry & Physics, College of Agriculture, Engineering & Science, Westville Campus, University of KwaZulu-Natal, Durban, South Africa.
ORCID-Profile: Lova Gani Raju Bandaru, Phani Raja Kanuparthy, Nagalakshmi Jeedimalla, Bhukya Vijay Nayak, Jayaprakash Kanijam Raghupathi, Naresh Kumar Katari, Rambabu Gundla
Zitieren
APA
Bandaru, L. G. R., Kanuparthy, P. R., Jeedimalla, N., Nayak, B. V., Raghupathi, J. K., Katari, N. K., & Gundla, R. (2024). Stability indicating RP‐HPLC method development and validation for quantification of impurities in gonadotropin‐releasing hormone (Elagolix): Robustness study by quality by design. Biomedical Chromatography. https://doi.org/10.1002/bmc.6036
Vancouver
Bandaru LGR, Kanuparthy PR, Jeedimalla N, Nayak BV, Raghupathi JK, Katari NK, et al. Stability indicating RP‐HPLC method development and validation for quantification of impurities in gonadotropin‐releasing hormone (Elagolix): Robustness study by quality by design. Biomedical Chromatography. 2024. doi:10.1002/bmc.6036
BibTeX
@article{Bandaru2024,
author = {Bandaru, Lova Gani Raju and Kanuparthy, Phani Raja and Jeedimalla, Nagalakshmi and Nayak, Bhukya Vijay and Raghupathi, Jayaprakash Kanijam and Katari, Naresh Kumar and Gundla, Rambabu},
title = {Stability indicating RP‐HPLC method development and validation for quantification of impurities in gonadotropin‐releasing hormone (Elagolix): Robustness study by quality by design},
journal = {Biomedical Chromatography},
year = {2024},
doi = {10.1002/bmc.6036}
}
EUVIMED